Literature DB >> 16193837

Accuracy and diagnostic yield of stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimens.

Fügen V Aker1, Tayfun Hakan, Selhan Karadereler, Murat Erkan.   

Abstract

The aim of this retrospective study was to investigate the diagnostic yield and accuracy of stereotactic biopsy in patients harboring brain mass. Stereotactic biopsy was performed in 130 patients between 1995 and 2000 in an educational and research hospital in Turkey. The results of histological analysis were compared to the resected specimens in 23 patients. The lesions were lobar in 62% of cases and deep-seated in 38% of cases. During the biopsy procedures, the pathologist was in the operating theatre and a very small fragment was used for cytological examination. No frozen section was used in any of the cases. Samples were diagnostic in 122 cases. The overall diagnostic yield of the procedure was 94%. A definitive histological diagnosis was not made in eight patients. The histological diagnoses of the two procedures were identical (complete agreement) in 16 cases. In three cases, the histological diagnoses between the two procedures were slightly different without impact on patient care (minor disagreement). The diagnosis of the stereotactic biopsy was completely changed after craniotomy in four cases (major disagreement). The accuracy of the histological diagnosis was 83%. There was only one major complication, which involved intracerebral hemorrhage. Despite the limited number of patients who underwent resection, our data suggest that stereotactic biopsy of brain masses is a safe and accurate technique that can obtain adequate tissue for histological diagnosis, thus providing the best avaible treatment for patients. Cytological evaluation of the streotactic biopsy also is a highly effective tool for obtaining sufficient material during the procedure in many cases.

Entities:  

Mesh:

Year:  2005        PMID: 16193837     DOI: 10.1111/j.1440-1789.2005.00634.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  19 in total

1.  Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies.

Authors:  Georg Widhalm; Georgi Minchev; Adelheid Woehrer; Matthias Preusser; Barbara Kiesel; Julia Furtner; Aygül Mert; Antonio Di Ieva; Boguslaw Tomanek; Daniela Prayer; Christine Marosi; Johannes A Hainfellner; Engelbert Knosp; Stefan Wolfsberger
Journal:  Neurosurg Rev       Date:  2012-03-10       Impact factor: 3.042

2.  Sensitivity analysis aimed at blood vessels detection using interstitial optical tomography during brain needle biopsy procedures.

Authors:  Julien Pichette; Andréanne Goyette; Fabien Picot; Marie-Andrée Tremblay; Gilles Soulez; Brian C Wilson; Frédéric Leblond
Journal:  Biomed Opt Express       Date:  2015-10-05       Impact factor: 3.732

3.  Biopsy targeting with dynamic contrast-enhanced versus standard neuronavigation MRI in glioma: a prospective double-blinded evaluation of selection benefits.

Authors:  Vera C Keil; Bogdan Pintea; Gerrit H Gielen; Susanne Greschus; Rolf Fimmers; Jürgen Gieseke; Matthias Simon; Hans H Schild; Dariusch R Hadizadeh
Journal:  J Neurooncol       Date:  2017-04-19       Impact factor: 4.130

4.  Assessment of molecular markers demonstrates concordance between samples acquired via stereotactic biopsy and open craniotomy in both anaplastic astrocytomas and glioblastomas.

Authors:  Florian Gessler; Peter Baumgarten; Joshua D Bernstock; Patrick Harter; Stephanie Lescher; Christian Senft; Volker Seifert; Gerhard Marquardt; Lutz Weise
Journal:  J Neurooncol       Date:  2017-05-15       Impact factor: 4.130

5.  Correlation between magnetic resonance imaging findings and histological diagnosis of intrinsic brainstem lesions in adults.

Authors:  Marcos Dellaretti; Gustavo Touzet; Nicolas Reyns; François Dubois; Sebastião Gusmão; Júlio Leonardo Barbosa Pereira; Serge Blond
Journal:  Neuro Oncol       Date:  2012-01-05       Impact factor: 12.300

6.  Diagnostic challenges, management and outcomes of midline low-grade gliomas.

Authors:  Mueez Waqar; Shahid Hanif; Nitika Rathi; Kumar Das; Rasheed Zakaria; Andrew R Brodbelt; Carol Walker; Michael D Jenkinson
Journal:  J Neurooncol       Date:  2014-08-06       Impact factor: 4.130

7.  Towards improving the safety and diagnostic yield of stereotactic biopsy in a single centre.

Authors:  Ruben Dammers; Joost W Schouten; Iain K Haitsma; Arnaud J P E Vincent; Johan M Kros; Clemens M F Dirven
Journal:  Acta Neurochir (Wien)       Date:  2010-08-01       Impact factor: 2.216

Review 8.  The role of biopsy in the management of patients with presumed diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Authors:  Brian T Ragel; Timothy C Ryken; Steven N Kalkanis; Mateo Ziu; Daniel Cahill; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2015-11-03       Impact factor: 4.130

9.  Central nervous system involvement of T-cell prolymphocytic leukemia diagnosed with stereotactic brain biopsy: case report.

Authors:  Selçuk Göçmen; Murat Kutlay; Alev Erikçi; Cem Atabey; Ozkan Sayan; Aptullah Haholu
Journal:  Turk J Haematol       Date:  2014-03-05       Impact factor: 1.831

Review 10.  Clinical outcomes as a function of the number of samples taken during stereotactic needle biopsies: a meta-analysis.

Authors:  Sanjay Dhawan; Andrew S Venteicher; William E Butler; Bob S Carter; Clark C Chen
Journal:  J Neurooncol       Date:  2021-07-12       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.